Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pediatric Glittre ADL-test in Children With Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03985956
Recruitment Status : Recruiting
First Posted : June 14, 2019
Last Update Posted : June 18, 2019
Sponsor:
Information provided by (Responsible Party):
Muserrefe Nur Keles, Gazi University

Brief Summary:
The aim of the study is to investigate reliability, validity, of the Glittre ADL Test in children with Asthma.

Condition or disease
Asthma in Children

Detailed Description:
The TGlittre-P is an adaptation of the TGlittre test for pediatric patients. It consists of completing a circuit while carrying a backpack with a variable weight of 0.5 kg to 2.5 kg, according to the child´s age and sex. This weight range follows the guidelines of the World Health Organization, which states that the younger the female child is, the lighter the backpack should be, in order to assure the school children´s health condition. The following tasks should be carried out; from a sitting position, the child stands up and walks along a 10m-long flat course, going up and down a 2-step rise (17 cm high x 27 cm wide) about halfway along that distance, to reach a bookshelf with three 0.5 kg objects (i.e. colorful plastic bowling pins filled with sand). The objects are placed on the top shelf at eye level, which should be removed, one by one, to the lower shelf at the level of the umbilicus, and then to the ground. Next, the objects should be placed on the lower shelf and then back to the top shelf. The child walks back along the same route. (S)he sits down, stands up and immediately starts the next lap. The following verbal instructions are given during the test: "sit" and "stand." The time required to walk five laps is registered; the less the time spent, the better the performance is. The test performance was evaluated by comparing the patient´s data with the data predicted by the equation, in his study with healthy children. The equation for girls is "time in TGlittre-P = 3.781-0.083 x AGE"; and boys, "time in TGlittre-P = 4.025-0.123 x AGE".

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: The Validity and Reliability of the ADL-Glittre Test as a Measure of Functional Capacity in Children With Asthma
Actual Study Start Date : June 1, 2019
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : July 10, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma




Primary Outcome Measures :
  1. Glittre ADL test [ Time Frame: 15 minutes ]
    Functional test


Secondary Outcome Measures :
  1. Six Minute Walk Test [ Time Frame: 10 mimutes ]
    Exercise Test



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Children with asthma who apply to Gazi University, Department of Physiotherapy and Rehabilitation will be invited to this study.
Criteria

Inclusion Criteria:

  • Children and adolescents aged 6-14 years with a diagnosis of Asthma
  • Task-oriented and co-operative patients without any musculoskeletal, rheumatic, neurological, hearing and visual diseases and without pulmonary exacerbation at the time of data collection will be included in this study.

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03985956


Contacts
Layout table for location contacts
Contact: Müşerrefe N Keleş, PhD 03122162643 muserref-1@hotmail.com
Contact: Bulent Elbasan bulentelbasan@gmail.com

Locations
Layout table for location information
Turkey
Gazi University, Faculty of Health and Sciences, Department of Physiotherapy and Rehabilitation Recruiting
Ankara, Turkey, 06500
Contact: Muserref Nur Keles, Phd    +905426622464    muserref-1@hotmail.com   
Sponsors and Collaborators
Gazi University
Investigators
Layout table for investigator information
Principal Investigator: Müşerrefe N Keleş Gazi University

Layout table for additonal information
Responsible Party: Muserrefe Nur Keles, PhD, PT, Research Assistant, Gazi University
ClinicalTrials.gov Identifier: NCT03985956     History of Changes
Other Study ID Numbers: 13579
First Posted: June 14, 2019    Key Record Dates
Last Update Posted: June 18, 2019
Last Verified: June 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Muserrefe Nur Keles, Gazi University:
Daily Living Activities
Exercise
Additional relevant MeSH terms:
Layout table for MeSH terms
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases